HIKMA PHARMACEUTICALS PLC ANNUAL REPORT 2015 Financial Statements Continued Notes to the Consolidated Financial Statements Continued 6.
Profit for the year Profit for the year has been arrived at after charging: 2015 2014 $m $m Net foreign exchange losses 6 6 Depreciation and impairment of property, plant and equipment 51 49 Amortisation and impairment of intangible assets including software 22 23 Inventories: Cost of inventories recognised as an expense 367 378 Write-down of inventories 29 32 Staff costs note 7 362 344 The Group auditors remuneration on a worldwide basis was as below: 2015 2014 $m $m Audit of the Companys annual accounts 0.4 0.4 Audit of the Companys subsidiaries pursuant to legislation 1.2 1.2 Total audit fees 1.6 1.6 Assurance services 0.1 0.2 Total audit and assurance fees 1.7 1.8 - Tax compliance services 0.1 0.1 - Tax advisory services 0.3 0.4 - Other services 2.5 Total non-audit fees 2.9 0.5 Total fees 4.6 2.3 Assurance services relate to review procedures in respect of the interim financial information.
Other services include transaction services, in particular relating to the Roxane prospectus class one circular.
A description of the work of the Audit Committee is set out in the Audit Committee report on pages 84 to 88 and includes an explanation of how auditor objectivity and independence is safeguarded when non-audit services are provided by the auditor.
Staff costs The average monthly number of employees including Executive Directors was: 2015 2014 Number Number Production 3,896 3,986 Sales and marketing 2,164 2,089 Research and development 264 223 General and administrative 865 841 7,189 7,139 152 152
